You are here:
Here you can see our projects that are open to the public. Filter according to your interests.
Development of a robust and cost-effective microfluidic chip that enables the reliable quantification of genomic and proteomic biomarkers in serially collected liquid biopsies from individuals at high risk for pancreatic cancer.
Das Kild-Projekt entwickelt ein innovatives Ultraschall-Wasserdurchflussmesssystem mit KI-basierter Leckage-Detektion. Dieses kostengünstige Retrofit-System ermöglicht eine einfache Installation und erkennt Leckagen zuverlässig, um Wasserschäden zu minimieren.
Das ULTRA-SAVE-Projekt entwickelt ein innovatives, ultraschallbasiertes Sensorsystem zur Überwachung von Pflanzenzuständen in konventioneller und hydroponischer Landwirtschaft. Durch den Einsatz von KI ermöglicht es präzise und nachhaltige Bewässerung sowie Früherkennung von Pflanzenstress und Krankheiten.
In the VIROTEC project, the team from Hahn-Schickard, Therawis Diagnostics GmbH, Rodinger Kunststoff-Technik GmbH and the institute for immunology of the TU Munich are planning to research a fully automated lateral flow test system for analysing organ-specific virosomes at the point of care.
The aim of the project is to develop an automated sample preparation for the mass spectrometric detection of metabolic biomarkers in patient samples on the basis of centrifugal microfluidics.
In the MINERVA project, a novel sample preparation for the analysis of the immunopeptidome by mass spectrometry is being developed on the basis of microfluidics with innovative, loss-minimising surface coatings. In the future, this should make patient-specific cancer therapies possible.
In 105°scaled, hydrocarbon-based membrane electrode assemblies (MEAs) are being developed for both fuel cells and electrolysis to be competitive with established PFAS-based MEAs.
Holistic sepsis diagnostics and management through combined molecular biology and immunology testing on an integrated, automated platform for an improved and personalized therapeutic approach.
Hahn-Schickard coordinates the “Zukunftscluster nanodiag BW” together with the University of Freiburg. As part of the German federal government's "Clusters4Future" initiative, the Hahn-Schickard sites in Freiburg and Villingen-Schwenningen are involved in several scientific and strategic projects.
Liquid biopsy enables the minimally invasive early detection of tumors and their progression. KI-VesD-2 assesses the innate immune response to tumor development by extracting extracellular vesicles (EV) from blood and analyzing them using artificial intelligence.
The aim of this project is the development of a platform for molecular diagnostic characterization of the immune response in viral diseases from blood serum. The platform shall be usable for high throughput professional laboratory diagnostics as well as decentralized at the point of care.
The selective organoid handling platform (SpheroPro) developed in ADAPT will be extended in ADAPT-2 to include an AI-assisted selection of suitable 3D cell culture models and a 3D imaging module based on holographic tomography for non-invasive and label-free analysis of organoids and spheroids.
The earliest possible diagnosis of cancer and the detection of therapy resistance are of utmost importance in order to maximize the survival chances of those affected. In the EV-Surf project, a new method for diagnosing cancers based on liquid biopsies is being researched.
The aim of the project is to make proteome data usable for the stratification of clear cell renal carcinoma patients and thus maximise the chances of therapeutic success.
The WUMMS project is investigating a mobile, multimodal diagnostic platform with telemedicine connectivity for on-site analysis of chronic wounds. The platform to be developed combines the performance of laboratory-based molecular detection methods with the advantages of rapid tests.
